These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34926580)

  • 1. 5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer.
    Wang K; Zhong W; Long Z; Guo Y; Zhong C; Yang T; Wang S; Lai H; Lu J; Zheng P; Mao X
    Front Mol Biosci; 2021; 8():775304. PubMed ID: 34926580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma.
    Pan Q; Yi C; Zhang Y
    Front Oncol; 2022; 12():884377. PubMed ID: 35686101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic signature and immune landscape of 5-methylcytosine-related long non-coding RNAs in gastric cancer.
    Song Q; Wu J; Wan H; Fan D
    Heliyon; 2024 Sep; 10(18):e37290. PubMed ID: 39323814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel prognosis model based on m5C-related long non-coding RNAs in colorectal cancer.
    Di Z; Xu G; Ding Z; Li C; Song J; Huang G; Zheng J; Zhang X; Xiong B
    Cancer Cell Int; 2023 Sep; 23(1):196. PubMed ID: 37670275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies.
    Tan X; Cai Z; Chen G; Cai C; Chen J; Liang Y; Zhuo Y; Liu J; Huang L; Ouyang B; Wei Y; Jia Z; Deng J; Zhong W; Lu J
    Discov Oncol; 2023 May; 14(1):62. PubMed ID: 37155024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma.
    Xu Z; Chen S; Zhang Y; Liu R; Chen M
    Front Immunol; 2022; 13():869759. PubMed ID: 35603206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A five-pseudouridylation-associated-LncRNA classifier for primary prostate cancer prognosis prediction.
    Zheng P; Long Z; Gao A; Lu J; Wang S; Zhong C; Lai H; Guo Y; Wang K; Fang C; Mao X
    Front Genet; 2022; 13():1110799. PubMed ID: 36704346
    [No Abstract]   [Full Text] [Related]  

  • 9. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
    Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
    Front Genet; 2022; 13():903117. PubMed ID: 35692827
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas.
    Zhang J; Wang N; Wu J; Gao X; Zhao H; Liu Z; Yan X; Dong J; Wang F; Ba Y; Ma S; Jin J; Du J; Ji H; Hu S
    Front Immunol; 2022; 13():844778. PubMed ID: 35309316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signature of m5C-Related lncRNA for Prognostic Prediction and Immune Responses in Pancreatic Cancer.
    Liu X; Wang D; Han S; Wang F; Zang J; Xu C; Dong X
    J Oncol; 2022; 2022():7467797. PubMed ID: 35211172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma.
    Pan J; Huang Z; Xu Y
    Front Cell Dev Biol; 2021; 9():671821. PubMed ID: 34268304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer.
    Mulati Y; Lai C; Luo J; Hu J; Xu X; Kong D; Xiao Y; Liu C; Xu K
    BMC Cancer; 2024 Jan; 24(1):44. PubMed ID: 38191330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of m5C-Related lncRNAs in the prognosis and immune landscape of hepatocellular carcinoma.
    Lu Q; Liu L; Wang S; Zhang Q; Li L
    Front Genet; 2022; 13():990594. PubMed ID: 36339006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer.
    Xu H; Lu M; Liu Y; Ren F; Zhu L
    J Cancer; 2023; 14(16):3151-3168. PubMed ID: 37859811
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer.
    Tang L; Li W; Xu H; Zheng X; Qiu S; He W; Wei Q; Ai J; Yang L; Liu J
    Front Oncol; 2022; 12():876531. PubMed ID: 35860569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of Prognostic Risk Model of 5-Methylcytosine-Related Long Non-Coding RNAs and Evaluation of the Characteristics of Tumor-Infiltrating Immune Cells in Breast Cancer.
    Huang Z; Li J; Chen J; Chen D
    Front Genet; 2021; 12():748279. PubMed ID: 34777473
    [No Abstract]   [Full Text] [Related]  

  • 19. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
    Wu J; Cai Y; Zhao G; Li M
    J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer.
    Peng Y; Xu C; Wen J; Zhang Y; Wang M; Liu X; Zhao K; Wang Z; Liu Y; Zhang T
    Front Oncol; 2021; 11():704038. PubMed ID: 34458145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.